The effect of chondroitin sulphate (CS) on peritoneal fluid and solute transport was studied in rats undergoing peritoneal dialysis. In the presence of CS, net ultrafiltration increased, while absorption of glucose and horseradish peroxidase from the peritoneal cavity decreased. Albumin, used instead of CS, did not modify either fluid or solute transport.
S
everal methods have been proposed to modify water and solute removal during peritoneal dialysis. Synthetic polyanionic polymers used as osmotic substances in the dialysis fluid increase net fluid ultrafiltration mainly because of their slow absorption from the peritoneal cavity (1) . However , they have limited application during peritoneal dialysis because of their toxicity.
We present results of our study with the naturally occurring polyanionic polymer -glycosaminoglycan chondroitin sulphate (CS) -as an alternative osmotic substance modifying peritoneal transport kinetics.
MATERIAL AND METHODS

IN VIVO EXPERIMENTS
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Received January 14, 1991; accepted April 10, 1991. of300 g (range 240-340) were dialysed with a dialysis solution having the following composition (in mM): sodium -135, chloride -135, glucose -50, and an osmolality of 320 mOsm/kg. In addition, the dialysis solution contained horseradish peroxidase (HP) (mw 40,000). Control animals received the above dialysis solution; in 2 other experimental groups, chondroitin sulphate (1.6 g%) or bovine albumin (1.6 g%) was added to the dialysis solution. Addition of albumin or chondroitin sulphate to the dialysis fluid did not modify its osmolality. Under ether anesthesia, 8 mL/100 g bw of dialysis fluid was instilled into the peritoneal cavity through a 16-gauge polyvinyl catheter; then the animals were set free and given food and tap water ad libitum. The effects of anesthesia had disappeared 5-10 minutes after the infusion of the dialysis fluid. In each group of animals, we had 3 subgroups according to the dwell time of the dialysis solution (1,2, and 4 hours) ( Table 1) . At the end of the dwell time, again under ether anesthesia, the abdomen was opened and residual dialysate was collected with a Pasteur pipette. The total volume of the recovered fluid was determined by weight. Blood samples were drawn from the heart and then the animals were killed by bleeding.
The drained volume of dialysis fluid was expressed as a percentage of the volume infused. Protein concentration in serum and dialysate was measured by the Lowry method (2), and the results were expressed as dialysate/serum concentration ratio. Urea concentration in serum and dialysate was measured with an enzymatic method (Sigma, urea nitrogen test No640), and results were expressed as a ratio in the same ways as proteins. Glucose concentration was measured by an enzymatic method (Sigma, glucose test N°510). Dialysate horseradish peroxidase concentration was determined by measuring the peroxidatic activity (3) in the dialysate effluent.
Absorption of glucose and horseradish peroxidase from the dialysate was calculated according to the following formula:
IN VITRO EXPERIMENTS
The isolated rabbit mesentery was mounted on a chamber to study transmembrane water flow in duced by hydrostatic pressure, according to a method developed in our lab. The chamber has a cylindrical shape with the membrane (1 cm2) mounted at the bottom (Figure 1 ). Hanks solution was added to the chamber to a level of 1 cm above the surface of the membrane, and in this way the hydrostatic pressure applied was equal to 1 cm H2Ocm2. This force caused fluid to flow across the membrane, which was collected in a tube below the chamber. Fluid volume was measured gravimetrically. Every 30 minutes, the medium in the chamber was changed to keep the pressure above the membrane steady in every period of study. Transmembrane fluid flow rate was constant during the entire experiment -120 minutes. In 1 group of experiments, CS (1.6%) was added to Hanks solution between 30 and 120 minutes, and in another group between 30 and 60 minutes. In the latter group, we evaluated the reversibility of the CS effect by removing the solution with CS at 60 minutes and refilling the chamber with plain Hanks solution.
Statistical analysis of the data in the in viva and in vitra experiments was done using nonparametric tests for unpaired or paired data. A p value <0.05 was considered significant. Figure 2 shows the kinetics of dialysate volume changes in all studied groups of animals. When compared with the results in control rats, addition of albumin did not change the dialysate volume. In contrast, addition of CS increased the final volume significantly compared to controls and to those rats that had albumin in the dialysate. CS decreased the rate at which glucose and HP were absorbed from the peritoneal cavity (Figures 3 and 4) . In rats dialyzed with CS, dialysate/serum ratio of total protein was lower after 4 hours than it was in controls: 0.179&plusmn;0.013 versus 230&plusmn;0.008, p<0.05. Neither CS nor albumin changed the dialysate/serum urea ratio.
RESULTS
In in vitra experiments, CS decreased the transmesenteric water flow, and its effect was not totally reversible after 30 minutes of exposure ( Figure 5 ).
DISCUSSION
These results show that the polyanionic glycosaminoglycan chondroitin sulphate, when added to dialysis fluid, increased net removal of water and modified transperitoneal transport of proteins, glucose, and horseradish peroxidase, but did not affect urea transport. Another macromolecule, albumin, did not produce this effect when used in similar conditions. These observations suggest that the ef fect of CS is related to certain specific properties of this substance.
CS increased net transperitoneal removal ofwater during peritoneal dialysis in rats probably through more than 1 independent mechanism. Thus, CS slightly decreased the glucose absorption rate from the dialysate, which could cause a slower dissipation of glucose osmotic gradient across the membrane, and therefore higher transperitoneal ultrafiltration. We cannot explain the mechanism of this effect ofCS on glucose transport across the peritoneum. However, we believe that a more important mechanism for increased UF is a direct effect of CS on the permeability ofperitoneal membrane to water. In the in vitra experiments, CS decreased the flow of water across the isolated mesentery, which was induced by hydrostatic pressure.
Glycosaminoglycan molecules can enter the mesenteric interstitium and form a network, which may increase resistance to water flow (4). Preston et al. have shown that the resistance to water flow through a capillary filled with 1% hyaluronate was 107 times higher than the resistance of an empty capillary (5). After CS molecules have entered the peritoneal interstitium, they may be trapped there by becoming entangled with other interstitial glycosaminoglycans or collagen fibers. This mechanism may explain the slow reversibility of the CS effect during our in vitra experiments. We speculate that the decreased hydraulic permeability of the peritoneal membrane diminishes both ultrafiltration into the peritoneal cavity and simultaneous absorption of fluid from the peritoneal cavity. Water is transported into the peritoneal cavity by the osmotic gradient produced by dialysate glucose, which may still be effective when the peritoneal hydraulic conductivity is diminished. On the other hand, dialysate is absorbed from the peritoneal cavity at the peritoneal microvessels or the interstitial lymphatics where the driving force of negative hydrostatic pressure and serum-protein oncotic pressure is too low to overcome the augmented resistance of the peritoneal interstitium to water flow. As a result, water may enter the peritoneal cavity, albeit at a slower rate, and become trapped there because the absorption forces are too weak to counterbalance the decreased peritoneal hydraulic conductivity produced by the CS in the interstitium. Indeed, the effect of chondroitin sulphate on dialysis volume was stronger at the end of 4 hours of dialysis, when mainly absorption of fluid occurs. The hypothesis we presented here becomes more probable when one realizes that fluid filtration and reabsorpton at the arteriolar and venular part of the microvessels are caused by pressures of a few mm Hg. On the other hand, osmotic pressure, which pulls water across the peritoneum into the peritoneal cavity, is much higher, reaching a few miliosmoles ( 1 mOsm = 19 mm Hg).
CS also diminished bidirectional transport of proteins during the peritoneal dialysis. It had a greater effect on the absorption of proteins from the dialysate than on their influx into the peritoneal cavity. Again, one might propose several mechanisms for this action. First, the network of polyanionic glycosaminoglycans in the peritoneal interstitium may impede diffusion of proteins through this compartment (6) . Second, because the CS had a stronger effect on protein removal from the peritoneal cavity than on their intraperitoneal influx, we cannot rule out its action through the peritoneal lymphatics (7) .
The decrease in dialysate absorption induced by polyanionic CS may be a desirable effect during peritoneal dialysis. Further studies are needed to determine whether glycosaminoglycans may be one of a group of substances that have a clinical application in modulating transperitoneal transport of water and solutes.
